DarioHealth Corp., today announced a joint marketing agreement with Glytec, a pioneer of insulin titration solutions.
The agreement allows DarioHealth’s smart glucose meter (part of the Dario Blood Glucose Monitoring System) to transmit information to Glytec’s Glucommander™ Outpatient software-as-a-medical-device.
This will make the Dario® Blood Glucose Monitoring System available to hospitals and health systems using Glytec’s virtual insulin titration service for outpatients with diabetes.
Blood glucose data from the Dario Blood Glucose Monitoring System automatically sent to the Cloud in real-time, will be seamlessly imported to Glucommander Outpatient™ and utilized in conjunction with other clinical data to formulate personalized insulin dose recommendations.
The connected care model supports virtual insulin titration for outpatients with diabetes.
“The Dario Blood Glucose Monitoring System is growing in popularity among people with both Type 1 and Type 2 diabetes, and we are pleased to be able to add DarioHealth to our best-in-class network of connected device partners,” said Bob Leonard, Glytec’s President, and Chief Executive Officer. “Glytec doesn’t make devices, we make devices better by adding the missing element, which is insulin titration.”
He adds there is little that can be done to achieve and sustain significant A1c improvements with data alone, but by making that data actionable and making timely insulin dose adjustments, you can see average reductions in A1c of 2.7% points and higher over 12 months.
The Dario Blood Glucose Monitoring System combines five essential tools to simplify diabetes management: (1) a sleek, all-in-one smart glucose meter, (2) a personal diabetes progress monitor, (3) on-demand data sharing, (4) emergency hypoglycemia alerts with GPS locator, and (5) a carb counting tool.
“Glytec will benefit from real-time, accurate blood glucose data to provide insulin titration decision support, and we are convinced that the Dario Blood Glucose Monitoring System will be a more complete solution when paired with Glucommander™ Outpatient,” said Erez Raphael, DarioHealth’s Chief Executive Officer. “We believe that people with diabetes need this synergy to be most successful in managing their diabetes.”
- DarioHealth Partners With Glytec on Outpatient Diabetes Management. (2019, March 27). PRNewswire. Retrieved: https://prnmedia.prnewswire.com/news-releases/dariohealth-partners-with-glytec-on-outpatient-diabetes-management-300819237.html